Lexaria Bioscience Shares Outstanding 2018-2021 | LEXX

Lexaria Bioscience shares outstanding from 2018 to 2021. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Lexaria Bioscience Annual Shares Outstanding
(Millions of Shares)
2020 3
2019 3
2018 2
Lexaria Bioscience Quarterly Shares Outstanding
(Millions of Shares)
2021-05-31 5
2021-02-28 4
2020-11-30 3
2020-08-31 3
2020-05-31 3
2020-02-29 3
2019-11-30 3
2019-08-31 3
2019-05-31 3
2019-02-28 3
2018-11-30 3
2018-08-31 2
2018-05-31 2
2018-02-28 2
2017-11-30 2
2017-08-31
2017-05-31 2
2017-02-28 2
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.035B $0.000B
Lexaria Bioscience Corp. provides drug delivery platforms. Its patented DehydraTECH(TM) drug delivery technology changes the way Active Pharmaceutical Ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. Lexaria Bioscience Corp. is based in Kelowna, Canada.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $133.838B 8.91
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.341B 20.90
Biohaven Pharmaceutical Holding (BHVN) United States $8.723B 0.00
Emergent Biosolutions (EBS) United States $2.813B 6.79
Arcus Biosciences (RCUS) United States $2.568B 0.00
Myovant Sciences (MYOV) United Kingdom $2.170B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.949B 0.00
Zymeworks (ZYME) Canada $1.323B 0.00
Ambrx Biopharma (AMAM) United States $0.509B 0.00
SQZ Biotechnologies (SQZ) United States $0.428B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29